A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

Fariba Navid, Victor M. Santana, Michael Neel, M. Beth McCarville, Barry L. Shulkin, Jianrong Wu, Catherine A. Billups, Shenghua Mao, Vinay M. Daryani, Clinton F. Stewart, Michelle Kunkel, Wendene Smith, Deborah Ward, Alberto S. Pappo, Armita Bahrami, David M. Loeb, Jennifer Reikes Willert, Bhaskar N. Rao, Najat C. Daw

Research output: Contribution to journal › Article › peer-review